Skip to main content
. 2013 Mar;23(2):80–90. doi: 10.1089/cap.2012.0063

Table 1.

Concomitant Psychotropic Medication Treatment During Phase II

Rationale Entry criteria First line Second line Third line Other
Psychosis
n=1
Score≥3 on one of the key positive psychotic items of Brief Psychiatric Rating Scale for Children Risperidone
n=1
Quetiapine
n=0
Aripiprazole
n=0
N/A
Refractory mania
n=13
Young Mania Rating Scale score≥12 Valproate
n=11
Quetiapine
n=1
Aripiprazole
n=0
Risperidone
n=1
Depressive episode
n=0
Children's Depression Rating Scale-Revised score>28 for 2 weeks Lamotrigine
n=0
Quetiapine
n=0
Citalopram
n=0
N/A
Comorbid anxiety
n=2
Pediatric Anxiety Rating Scale impairment score≥3 Valproate
n=1
Quetiapine
n=2
Lamotrigine
n=0
N/A
Comorbid ADHD
n=15
ADHD Rating Scale score≥12 on hyperactivity-impulsivity or inattention subscale Methylphenidate
n=11
Mixed amphetamine salts
n=4
Atomoxetine
n=0
Risperidone
n=1
Othera
n=1
        Aripiprazole
n=1
a

Protocol deviation: patient was prescribed concomitant aripiprazole the reason for which was not discernable.

ADHD, attention-deficit/hyperactivity disorder.